You just read:

New Post-Hoc Analysis Supports YOSPRALA™ Efficacy And Safety In Previous Heart Attack Patients Who Need Daily Aspirin Therapy To Prevent A Second Cardiovascular Event

News provided by

Aralez Pharmaceuticals Inc.

14 Nov, 2016, 07:00 ET